Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

NCT04129502

Conditions
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • City of Hope National Medical Center Long Beach, California, United States
  • University of California Irvine Orange, California, United States
  • Stanford University Palo Alto, California, United States
  • AdventHealth Orlando, Florida, United States
View all 134 locations
View Trial Details
Active, Not Recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

NCT05853575

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • Local Institution - 101 Santa Rosa, California, United States
  • Local Institution - 105 Kansas City, Missouri, United States
  • Local Institution - 100 Durham, North Carolina, United States
  • Local Institution - 106 Dallas, Texas, United States
View all 98 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

NCT03391869

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +15 more
Locations
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson West Houston Houston, Texas, United States
  • MD Anderson League City League City, Texas, United States
View Trial Details

Related conditions